Global Albumin (as Excipient) Market Insights and Forecast to 2027
SKU ID : QYR-18077822 | Publishing Date : 22-Apr-2021 | No. of pages : 111
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
Market Analysis and Insights: Global Albumin (as Excipient) Market
The global Albumin (as Excipient) market is valued at US$ 4212 million in 2019. The market size will reach US$ 5835.9 million by the end of 2026, growing at a CAGR of 6.1% during 2021-2026.
Global Albumin (as Excipient) Scope and Market Size
Albumin (as Excipient) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Albumin (as Excipient) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Human Serum Albumin
Recombinant Albumin
In terms of type, Human Serum Albumin has the highest proportion of revenue, exceeding 98% in 2019.
Segment by Application
Cell Culture Media
Medical Supplements
Therapeutics
Therapeutics had the highest share of sales by application, at 73.27% in 2019.
By Company
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
Market Analysis and Insights: Global Albumin (as Excipient) Market
The global Albumin (as Excipient) market is valued at US$ 4212 million in 2019. The market size will reach US$ 5835.9 million by the end of 2026, growing at a CAGR of 6.1% during 2021-2026.
Global Albumin (as Excipient) Scope and Market Size
Albumin (as Excipient) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Albumin (as Excipient) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Human Serum Albumin
Recombinant Albumin
In terms of type, Human Serum Albumin has the highest proportion of revenue, exceeding 98% in 2019.
Segment by Application
Cell Culture Media
Medical Supplements
Therapeutics
Therapeutics had the highest share of sales by application, at 73.27% in 2019.
By Company
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.